Elizabeth Gould

878 total citations
15 papers, 719 citations indexed

About

Elizabeth Gould is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Elizabeth Gould has authored 15 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Elizabeth Gould's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Elizabeth Gould is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Elizabeth Gould collaborates with scholars based in United States, United Kingdom and Belgium. Elizabeth Gould's co-authors include Susan L. Ford, William Spreen, Stephen C. Piscitelli, David M. Margolis, Yu Lou, Herta Crauwels, Gary D. Bowers, Shuguang Chen, David Wilfret and Shuguang Chen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Elizabeth Gould

15 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Gould United States 12 540 387 169 83 64 15 719
Tsunefusa Hayashida Japan 14 423 0.8× 277 0.7× 202 1.2× 81 1.0× 53 0.8× 31 655
Maura Laverty United States 8 356 0.7× 243 0.6× 181 1.1× 53 0.6× 31 0.5× 15 517
Anthony T. Podany United States 18 573 1.1× 286 0.7× 220 1.3× 123 1.5× 81 1.3× 54 844
Nanci Hawley‐Foss Canada 10 298 0.6× 341 0.9× 160 0.9× 68 0.8× 33 0.5× 19 588
Akil Jackson United Kingdom 20 686 1.3× 525 1.4× 197 1.2× 79 1.0× 78 1.2× 52 888
Britt Stancil United States 9 455 0.8× 329 0.9× 207 1.2× 66 0.8× 62 1.0× 12 850
Neil Buss Switzerland 13 375 0.7× 252 0.7× 130 0.8× 98 1.2× 90 1.4× 17 655
Daniel Seekins United States 19 532 1.0× 324 0.8× 211 1.2× 62 0.7× 27 0.4× 30 746
Gregory E. Chittick United States 15 484 0.9× 287 0.7× 198 1.2× 78 0.9× 116 1.8× 18 798
Dan Duiculescu Romania 11 805 1.5× 628 1.6× 225 1.3× 92 1.1× 32 0.5× 22 949

Countries citing papers authored by Elizabeth Gould

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Gould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gould more than expected).

Fields of papers citing papers by Elizabeth Gould

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gould. The network helps show where Elizabeth Gould may publish in the future.

Co-authorship network of co-authors of Elizabeth Gould

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gould. A scholar is included among the top collaborators of Elizabeth Gould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gould. Elizabeth Gould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Johnson, Mark, Roxanne C. Jewell, Amanda Peppercorn, et al.. (2018). The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects. Pharmacology Research & Perspectives. 6(4). e00408–e00408. 16 indexed citations
2.
Markowitz, Martin, Ian Frank, Robert M. Grant, et al.. (2017). Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. The Lancet HIV. 4(8). e331–e340. 164 indexed citations
3.
Ford, Susan L., Elizabeth Gould, Yu Lou, et al.. (2017). Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women. British Journal of Clinical Pharmacology. 83(7). 1499–1505. 16 indexed citations
4.
Lou, Yu, Ann M. Buchanan, Shuguang Chen, et al.. (2016). Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects. Clinical Pharmacology in Drug Development. 5(6). 509–516. 9 indexed citations
5.
Reese, Melinda J., Gary D. Bowers, Joan E. Humphreys, et al.. (2015). Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment fromin vitrostudies and a clinical investigation with midazolam. Xenobiotica. 46(5). 445–456. 42 indexed citations
6.
Bowers, Gary D., Melinda J. Reese, Stephen C. Piscitelli, et al.. (2015). Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans. Xenobiotica. 46(2). 147–162. 46 indexed citations
7.
Spreen, William, Susan L. Ford, Shuguang Chen, et al.. (2014). GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(5). 481–486. 117 indexed citations
8.
Spreen, William, Peter Williams, David M. Margolis, et al.. (2014). Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(5). 487–492. 96 indexed citations
9.
Ford, Susan L., Elizabeth Gould, Shuguang Chen, et al.. (2013). Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744. Antimicrobial Agents and Chemotherapy. 57(11). 5472–5477. 72 indexed citations
10.
Hodge, Rebecca J., et al.. (2013). Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes. Clinical Pharmacology in Drug Development. 2(3). 213–222. 63 indexed citations
11.
Lou, Yu, Amanda Peppercorn, Elizabeth Gould, et al.. (2013). Effect of Intravenous Zanamivir on Cardiac Repolarization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(7). 701–709. 3 indexed citations
12.
Ford, Susan L., Elizabeth Gould, Shuguang Chen, et al.. (2012). Effects of Etravirine on the Pharmacokinetics of the Integrase Inhibitor S/GSK1265744. Antimicrobial Agents and Chemotherapy. 57(1). 277–280. 20 indexed citations
13.
14.
Kim, Joseph, Elizabeth Gould, Yu Lou, et al.. (2012). Drug interaction profile for GSK2248761, a next generation non‐nucleoside reverse transcriptase inhibitor. British Journal of Clinical Pharmacology. 74(2). 336–345. 11 indexed citations
15.
Shelton, Mark, et al.. (2011). Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 55(11). 5178–5184. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsunefusa Hayashida Breakdown of academic impact, for papers by Maura Laverty Breakdown of academic impact, for papers by Anthony T. Podany Breakdown of academic impact, for papers by Nanci Hawley‐Foss Breakdown of academic impact, for papers by Akil Jackson Breakdown of academic impact, for papers by Britt Stancil Breakdown of academic impact, for papers by Neil Buss Breakdown of academic impact, for papers by Daniel Seekins Breakdown of academic impact, for papers by Gregory E. Chittick Breakdown of academic impact, for papers by Dan Duiculescu
Rankless by CCL
2026